841
Views
0
CrossRef citations to date
0
Altmetric
Critical Care Nephrology and Continuous Kidney Replacement Therapy

Serum chemokine IL-8 acts as a biomarker for identifying COVID-19-associated persistent severe acute kidney injury

, &
Article: 2311316 | Received 09 May 2023, Accepted 23 Jan 2024, Published online: 02 Feb 2024

References

  • Su H, Yang M, Wan C, et al. Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China. Kidney Int. 2020;98(1):1–9. doi: 10.1016/j.kint.2020.04.003.
  • Nadim MK, Forni LG, Mehta RL, et al. COVID-19-associated acute kidney injury: consensus report of the 25th acute disease quality initiative (ADQI) workgroup. Nat Rev Nephrol. 2020;16(12):747–764. doi: 10.1038/s41581-020-00356-5.
  • Legrand M, Bell S, Forni L, et al. Pathophysiology of COVID-19-associated acute kidney injury. Nat Rev Nephrol. 2021;17(11):751–764. doi: 10.1038/s41581-021-00452-0.
  • Fisher M, Neugarten J, Bellin E, et al. AKI in hospitalized patients with and without COVID-19: a comparison study. J Am Soc Nephrol. 2020;31(9):2145–2157. doi: 10.1681/ASN.2020040509.
  • Chan L, Chaudhary K, Saha A, et al. AKI in hospitalized patients with COVID-19. J Am Soc Nephrol. 2021;32(1):151–160. doi: 10.1681/ASN.2020050615.
  • Kellum JA, Romagnani P, Ashuntantang G, et al. Acute kidney injury. Nat Rev Dis Primers. 2021;7(1):52. doi: 10.1038/s41572-021-00284-z.
  • Perinel S, Vincent F, Lautrette A, et al. Transient and persistent acute kidney injury and the risk of hospital mortality in critically ill patients: results of a multicenter cohort study. Crit Care Med. 2015;43(8):e269-75–e275. doi: 10.1097/CCM.0000000000001077.
  • Kellum JA, Sileanu FE, Bihorac A, et al. Recovery after acute kidney injury. Am J Respir Crit Care Med. 2017;195(6):784–791. doi: 10.1164/rccm.201604-0799OC.
  • Ronco C, Bellomo R, Kellum JA. Acute kidney injury. Lancet. 2019;394(10212):1949–1964. doi: 10.1016/S0140-6736(19)32563-2.
  • Akcay A, Nguyen Q, Edelstein CL. Mediators of inflammation in acute kidney injury. Mediators Inflamm. 2009;2009:137072–137012. doi: 10.1155/2009/137072.
  • Kesmez Can F, Ozkurt Z, Ozturk N, et al. Effect of IL-6, IL-8/CXCL8, IP-10/CXCL 10 levels on the severity in COVID 19 infection. Int J Clin Pract. 2021;75(12):e14970.
  • Codina H, Vieitez I, Gutierrez-Valencia A, et al. Elevated anti-SARS-CoV-2 antibodies and IL-6, IL-8, MIP-1beta, early predictors of severe COVID-19. Microorganisms. 2021;9(11):2259. doi: 10.3390/microorganisms9112259.
  • Sirota JC, Walcher A, Faubel S, et al. Urine IL-18, NGAL, IL-8 and serum IL-8 are biomarkers of acute kidney injury following liver transplantation. BMC Nephrol. 2013;14(1):17. doi: 10.1186/1471-2369-14-17.
  • Tan D, Zhao L, Peng W, et al. Value of urine IL-8, NGAL and KIM-1 for the early diagnosis of acute kidney injury in patients with ureteroscopic lithotripsy related urosepsis. Chin J Traumatol. 2022;25(1):27–31. doi: 10.1016/j.cjtee.2021.10.001.
  • Pérez-García F, Martin-Vicente M, Rojas-García RL, et al. High SARS-CoV-2 viral load and low CCL5 expression levels in the upper respiratory tract are associated with COVID-19 severity. J Infect Dis. 2022;225(6):977–982. doi: 10.1093/infdis/jiab604.
  • Rudemiller NP, Patel MB, Zhang JD, et al. C-C motif chemokine 5 attenuates angiotensin II-dependent kidney injury by limiting renal macrophage infiltration. Am J Pathol. 2016;186(11):2846–2856. doi: 10.1016/j.ajpath.2016.07.015.
  • Erez DL, Denburg MR, Afolayan S, et al. Acute kidney injury in children after hematopoietic cell transplantation is associated with elevated urine CXCL10 and CXCL9. Biol Blood Marrow Transplant. 2020;26(7):1266–1272. doi: 10.1016/j.bbmt.2020.02.024.
  • Huang H, Zhou H, Wang W, et al. Prediction of acute kidney injury, sepsis and mortality in children with urinary CXCL10. Pediatr Res. 2022;92(2):541–548. doi: 10.1038/s41390-021-01813-y.
  • Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA. 2016;315(8):801–810. doi: 10.1001/jama.2016.0287.
  • Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract. 2012;120(4):c179–84. doi: 10.1159/000339789.
  • Anderson BJ, Calfee CS, Liu KD, et al. Plasma sTNFR1 and IL8 for prognostic enrichment in sepsis trials: a prospective cohort study. Crit Care. 2019;23(1):400. doi: 10.1186/s13054-019-2684-2.
  • Mikacenic C, Price BL, Harju-Baker S, et al. A two-biomarker model predicts mortality in the critically ill with sepsis. Am J Respir Crit Care Med. 2017;196(8):1004–1011. doi: 10.1164/rccm.201611-2307OC.
  • Daniels JR, Ma JZ, Cao Z, et al. Discovery of novel proteomic biomarkers for the prediction of kidney recovery from dialysis-dependent AKI patients. Kidney360. 2021;2(11):1716–1727. doi: 10.34067/KID.0002642021.
  • Singh S, Long JP, Tchakarov A, et al. Tertiary lymphoid structure signatures are associated with immune checkpoint inhibitor related acute interstitial nephritis. JCI Insight. 2022. doi: 10.1172/jci.insight.165108.
  • Hasanvand A. COVID-19 and the role of cytokines in this disease. Inflammopharmacology. 2022;30(3):789–798. doi: 10.1007/s10787-022-00992-2.
  • McBride WT, Kurth MJ, Domanska A, et al. Blood and urinary cytokine balance and renal outcomes at cardiac surgery. BMC Nephrol. 2021;22(1):406. doi: 10.1186/s12882-021-02621-6.
  • de Fontnouvelle CA, Greenberg JH, Thiessen-Philbrook HR, et al. Interleukin-8 and tumor necrosis factor predict acute kidney injury after pediatric cardiac surgery. Ann Thorac Surg. 2017;104(6):2072–2079. doi: 10.1016/j.athoracsur.2017.04.038.
  • Liu KD, Altmann C, Smits G, et al. Serum interleukin-6 and interleukin-8 are early biomarkers of acute kidney injury and predict prolonged mechanical ventilation in children undergoing cardiac surgery: a case-control study. Crit Care. 2009;13(4):R104. doi: 10.1186/cc7940.
  • da Mata GF, Fernandes DE, Luciano EP, et al. Inflammation and kidney involvement in human viral diseases caused by SARS-CoV-2, HIV, HCV and HBV. J Venom Anim Toxins Incl Trop Dis. 2021;27:e20200154. doi: 10.1590/1678-9199-JVATITD-2020-0154.
  • Cheng Y, Zhang N, Luo R, et al. Risk factors and outcomes of acute kidney injury in critically ill patients with coronavirus disease 2019. Kidney Dis (Basel). 2021;7(2):111–119. doi: 10.1159/000512270.
  • Amrouche L, Desbuissons G, Rabant M, et al. MicroRNA-146a in human and experimental ischemic AKI: CXCL8-Dependent mechanism of action. J Am Soc Nephrol. 2017;28(2):479–493. doi: 10.1681/ASN.2016010045.
  • Sekido N, Mukaida N, Harada A, et al. Prevention of lung reperfusion injury in rabbits by a monoclonal antibody against interleukin-8. Nature. 1993;365(6447):654–657. doi: 10.1038/365654a0.
  • Melero I, Villalba-Esparza M, Recalde-Zamacona B, et al. Neutrophil extracellular traps, local IL-8 expression, and cytotoxic T-Lymphocyte response in the lungs of patients with fatal COVID-19. Chest. 2022;162(5):1006–1016. doi: 10.1016/j.chest.2022.06.007.
  • Kim IS, Kim DH, Lee HW, et al. Role of increased neutrophil extracellular trap formation on acute kidney injury in COVID-19 patients. Front Immunol. 2023;14:1122510. doi: 10.3389/fimmu.2023.1122510.
  • Kwon O, Ahn K, Zhang B, et al. Simultaneous monitoring of multiple urinary cytokines may predict renal and patient outcome in ischemic AKI. Ren Fail. 2010;32(6):699–708. doi: 10.3109/0886022X.2010.486496.